Abiopharma

🔍 MAZZELLA JOSEPH F (Director)

Company: PennyMac Financial Services, Inc. (PFSI)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 359 shares of Common Stock at $93.03 per share (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 81,905.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: Mazzella Family Irrevocable Trust | shares_owned_after: 165,031.00

Footnotes:

• F1: The Reporting Person received these shares in lieu of cash compensation payable for services rendered as a non-management director of Issuer during the previous quarter. The transaction is exempt under Rule 16b-3 of the Securities Exchange Act of 1934.